Webcasts
Translate your idea into product: AI-driven antibody discovery at Evotec
October 18th 2022October 18, 2022, 2pm EDT Evotec recently hosted its Innovation Week webinar series - 5 virtual sessions over 5 days. Session 5 discusses Evotec’s capabilities for supporting all activities across the R&D continuum for biotherapeutics, i.e. Discovery and optimization of novel antibodies for specific disease targets, evaluation of lead antibodies for disease efficacy and safety, alongside process development and manufacturing
Best Practices in HCP Assay Development and Integration of Advanced Orthogonal Methods
October 11th 2022Tuesday, October 11, 2022 at 11 AM EDT Learn about best practices in Host Cell Protein (HCP) assay development and qualification. Improve your understanding of the advanced orthogonal methods used to fully characterize HCPs in your process
Automated High Throughput SEC Native Mass Spectrometry for mAb Screening
September 22nd 2022Thursday, September 22nd, 2022 9:00am EDT|6:00am PDT|2:00pm BST|3:00pm CEST 2:00pm EDT|11:00am PDT|7:00pm BST|8:00pm CEST See how RapidFire automated size exclusion chromatography (SEC) combined with the power of ion mobility mass spectrometry (IM-MS) enables efficient biotherapeutic development.
Advantages of a One-Stop Shop for Freeze/Thaw And Cold-Chain Process Development
September 21st 2022Wed, Sep 21, 2022 2:00 PM EDT This webinar will review the key considerations and gaps in evaluating freeze/thaw solutions, examine the elements of a dedicated technology center to bridging these gaps and development risks, and explore successful case studies of a technology center optimizing processes and speed-to-market.
Developing GMP-Manufactured Cas9 Proteins for Therapeutic Applications
June 30th 2022Thursday, June 30, 2022 at 11am PST | 1pm CST | 2pm EST As CRISPR based gene editing progresses from research to therapeutic applications, there is a growing need for high quality GMP grade materials, including the Cas9 protein and supporting instruments, and to minimize off target events. This webinar will discuss the development process of a GMP-manufactured Cas9 protein along with causes of off target events and how to minimize risk with high fidelity Cas9 protein.
Industrializing High-Throughput Glycoproteomics Using AI for Clinical Use
April 26th 2022Aberrant glycosylation of proteins has been implicated in key steps of disease biology, including the hallmarks of cancer as well as inflammation cascades associated with autoimmunity and aging. InterVenn Biosciences harnesses the predictive powers of artificial intelligence combined with cutting edge mass spectrometry to discover clinically relevant biomarkers that can only be revealed by high-resolution analysis of the glycoproteome.
Plan Now or Fail Later: Why raw materials matter
April 13th 2022Wednesday, April 13, 2022 at 2pm EST | 1pm CST | 11am PST Selecting raw materials for developing and manufacturing is not a trivial decision. Join us and learn how to avoid mistakes in raw material selection that can delay or prevent a promising mRNA therapeutic or vaccine from reaching the market..
Oligonucleotide Purification and Characterization - Tips for Success
March 30th 2022Wednesday, March 30th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Applying the appropriate tools for oligonucleotide purification and subsequent analysis is a unique challenge requiring application specific solutions. Join Drs. Anne Blackwell and Matthew L. Turner of Agilent Technologies for tips on oligonucleotide analysis and purification with Agilent’s suite of Bio LC solutions.
